chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Pruritus, Rhinorrhoea, Wheezing
Clinical narrative: runny nose; slight chest tightness; wheezing; face flushed red; face flushed red; headache; chest skin got itchy; stomach cramps; bouts of diarrhea; This is a spontaneous report from a contactable consumer (patient).  A 69 years old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EN6205) via an unspecified route, administered in Left Arm on 02Mar2021 at 16:30 (69-year-old at vaccination) as Dose 1, Single for Covid-19 immunization. The patient was non-pregnant at time of vaccination. The patient's medical history included stage 1 breast cancer IDC, diagnosed in Oct20219, seasonal allergy, dust allergy, avocado allergy, some food allergies, sensitive to many foods, known allergies to sulfa drugs. The patient's concomitant medication(s) included exemestane, docosahexaenoic acid, eicosapentaenoic acid (OMEGA 3), pravastatin, ergocalciferol (VIT D), ascorbic acid (VIT C), calcium carbonate (CALCI) within two weeks of vaccination. The patient previously took ciprofloxacin (CIPRO), MACRODANTIN and experienced allergy. The patient had not received any other vaccine in four weeks prior vaccination. On 02Mar2021 (after first dose of vaccination), the patient had experienced with headache at 16:45 after vaccination; chest skin got itchy, 55min; face flushed red, 120 min; runny nose and slight chest tightness and wheezing began. Most symptoms went away within 5-6 hrs. No injection site pain at all, but stomach cramps and bouts of diarrhea lasting a week.  She was advised by her allergist not to get dose 2 of vaccine. The outcome of the events was recovered on an Mar2021.  No follow-up attempts are possible. No further information is expected.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Headache, Pain in extremity, Pyrexia
Clinical narrative: Fever; Chills; Aches & pains in legs; Headache; This is a spontaneous report from a contactable consumer. A 54-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: EN6205; Expiration Date: 30Jun2021, at the age of 54 years), dose 1 via an unspecified route of administration, administered in Arm Left on 08Mar2021 10:15 as 1st dose, single for COVID-19 immunisation (age at vaccination: 54-year-old). Medical history included blood pressure and cholesterol abnormal. Concomitant medications included rosuvastatin calcium, lisinopril, triamterene taken for blood pressure abnormal from an unspecified start date. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 08Mar2021 the patient experienced headache. On 09Mar2021 aches & pains in legs, fever, chills. It was reported that has been taking Tylenol every four hours and that seems to help, and her legs aren't as bad now as she has been staying off of them. Clarified she received the first dose of the Pfizer COVID 19 vaccine 08Mar2021 at 10:15AM in the left arm. States she had a little headache Monday afternoon and then it was a steady headache on Tuesday; Tuesday her legs started to ache; then at 15:30 in the afternoon after work she was getting the chills and she took her temperature, and it was 99.8. Today she had to stay home from work; her temperature is 100.0; she was wearing long pajamas with a blanket as she was still cold. on 10Mar2021 the patient underwent lab tests and procedures which included body temperature: 99.8. on 11Mar2021 body temperature: 100. The outcome of the events headache was reported as recovered on 10Mar2021, Aches & pains in legs was recovering and fever and chills was not recovered.  No follow-up attempts are possible; No further information expected.
Sex: M
Vaccine: COVID19
Symptoms: Chills, Diarrhoea, Pyrexia, Vomiting
Clinical narrative: Chills; Fever; I threw up; Diarrhea; This is a spontaneous report from a contactable consumer (patient). A 66-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot number: EN6199 FHN 6-21 not clarified further), via an unspecified route of administration on an unspecified date as single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient was calling to report a few side effects from the first shot patient had. When probed for the side effects, patient stated, "patient had chills, fever, threw up and diarrhea on an unspecified date. The outcome of events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Swelling face
Clinical narrative: Face is kind of a little bit swollen, more like in the down area below the nose like her mouth and her chin that's where the most swelling is; This is a spontaneous report from a non-contactable consumer or other non-health care professional. This consumer reported for a female patient (Aunt of reporter). A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, batch/lot number was not reported) via an unspecified route of administration on 09Mar2021 as dose 1, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. Reporter stated that the patient had the Pfizer vaccine two days before the time of reporting, and she was having a lot of the side effects. On 11Mar2021, the day of reporting, the patient experienced "face was kind of a little bit swollen, more like in the down area below the nose like her mouth and her chin that's where the most swelling was". The reporter read that it was normal, but the patient wanted to make sure that it was okay. The reporter further stated that the swelling was more like in the down area, below the nose like her mouth and her chins that's where the most swelling was, just a little bit". The patient was worried that whether she should get the second dose. The reporter wanted to know whether experienced people in Pfizer recommend something to make this feel better with symptoms that the patient was experiencing. The clinical outcome for the events was unknown. Limited information was available over the call.   No follow-up attempts are Possible. Information on Lot/batch number cannot be obtained.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Rash erythematous, Rash pruritic
Clinical narrative: Red, itchy rashes; Red, itchy rashes; This is a spontaneous report from a non-contactable consumer (patient herself). A 43-years-old non-pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, lot number and expiration date was not reported) via an unspecified route of administration, administered in Arm Right on 03Mar2021 (at the age of 43-years-old) as DOSE 1, SINGLE for COVID-19 immunization. Patient was not pregnant at the time of vaccination. Medical history included Crohn's disease, COVID-19 from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. The patient previously took humira and purinethol and experienced drug hypersensitivity. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced red, itchy rashes (rash pruritic and rash erythematous) on 04Mar2021. Patient did not receive any treatment for adverse event. Since the vaccination, patient has not been tested for COVID-19. The outcome of both the events was recovered on an unspecified date in Mar2021.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Lip pruritus, Pruritus, Rash, Throat irritation, Vaccination site pain
Clinical narrative: Soreness at injection site; rash on neck; scratchy and itchy throat; itchy lips; itchy skin; This is a spontaneous report from a contactable other healthcare professional (patient). A 36-year-old female non-pregnant patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot number: ENG 6199, Expiration date: not reported), via an unspecified route of administration in arm left on 06Mar2021 at 13:45 (at the age of 36-year-old) as a dose 1, single for COVID-19 immunization. The patient's medical history included Hypothyroidism, ADHD, GAD. The patient had no known allergies. The patient's concomitant medications in two weeks included lisdexamfetamine mesylate (VYVANSE), guanfacine hydrochloride (INTUNIV), escitalopram, levothyroxine sodium (SYNTHROID), vitamin, all were taken for an unspecified indication. It was reported that, the patient was not pregnant at time of vaccination. No other vaccine in four weeks. No covid prior vaccination and no covid tested post vaccination. On 06Mar2021 at 18:00, the patient experienced soreness at injection site, rash on neck, scratchy and itchy throat, itchy lips, itchy skin. Treatment was not received for the events. The outcome of the events was recovering.  No follow up attempts are possible. No further information is expected.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Pyrexia
Clinical narrative: Headache; Fever; Chills; This is a spontaneous report from a contactable consumer (patient) reported for herself. A 58-years-old female patient (patient was not pregnant at the time of vaccination) received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: EN6203, Expiration date: unknown) via an unspecified route of administration, administered in left arm on 10Mar2021 at 13:00 pm (age at vaccination was 58 years) as dose 2, single for COVID-19 immunization. The patient did not have any medical history. The patient did not have any known allergies. The patient did not receive any concomitant medications or other vaccine in two weeks. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: EL3247, Expiration date: unknown) via an unspecified route of administration, administered in left arm on 17Feb2021 at 10:00 am (age at vaccination was 58 years) as dose 1, single for COVID-19 immunization. The facility where the most recent COVID-19 vaccine was Workplace clinic. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. On 11Mar2021 at 05:00 am, the patient experienced headache, fever and chills. No treatment was received for the adverse events. The outcome of the events was resolved on an unspecified date in 2021.  No follow-up attempts are possible. No further information is expected.
Sex: U
Vaccine: COVID19
Symptoms: Allergy to vaccine, Erythema, Heart rate, Heart rate increased, Hot flush
Clinical narrative: Redness in face; Flush hot face and neck; Rapid heartbeat; minor allergic reaction to the vaccine; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number: EN6203, Expiration date: Unknown), via an unspecified route of administration on an unspecified date in Mar2021 as DOSE 1, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. Additional context stated that the patient received first dose of the Pfizer vaccine couple weeks ago within the Mar2021 and was scheduled to have the second dose next week reported as a week from today or tomorrow. When the patient was there, the patient had a minor allergic reaction to the vaccine about 3 to 5 minutes shortly after the shot in the arm. The patient had redness in face, flush hot face and neck and felt rapid heartbeat and it lasted for 3-10 minutes. The patient was monitored by a women, they didn't give any Epipen or any thing like that and was recommended that the patient should get some allergy testing before second dose. The patient had not done that and didn't really think all of that was necessary. The patient underwent lab tests and procedures which included heart rate: rapid on an unspecified date in Mar2021. The outcome of the events recovered on an unspecified date in Mar2021.  No follow-up attempts are completed; information about lot/batch number cannot be obtained.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Pain, Swelling
Clinical narrative: have an Easter egg sized red painful swelling; have an Easter egg sized red painful swelling; have an Easter egg sized red painful swelling; This is a spontaneous report from a contactable Physician (patient). A 51-years-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: EN6198), via an unspecified route on 07Mar2021 (at the age of 51-years) as dose 1, single in the left arm for covid-19 immunisation. The patient medical history included known allergies to skin allergies to fragrances and certain cosmetics. The patient concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any other medications in two weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On unspecified date, the patient had an easter egg sized red painful swelling. It started within 12 hours. It was still there today 4 days later. Patient did not received treatment for events. The outcome of the events was not recovered.  No follow-up attempts are possible. No further information is expected.
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Nasal congestion, Oedema peripheral
Clinical narrative: cough; congestion; adema both legs and feet.; This is a spontaneous report from a non-contactable consumer. A 83-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: GL3246 and expiry date was not reported) via an unspecified route of administration, administered in Arm Left on 04Mar2021 18:00 (age at vaccination 83-years-old) as unknown, single for covid-19 immunisation. Medical history included chronic obstructive pulmonary disease from an unknown date and unknown if ongoing. The patient concomitant medications were not reported. Patient has not taken any other vaccine with in four vaccines. On 07Mar2021 06:00 PM, patient experienced Cough, congestion, adema both legs and feet. No treatment taken for AE. Patient has stated that she had not been diagnosed with COVID -19 prior to vaccination and not been tested since the vaccination. Outcome of the events was recovering.  No follow-up attempts are possible. No further information is expected.
Age: 34.0
Sex: M
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: covid-19-antibody; right subclavicular lymph nodes swelling; This is a spontaneous report from a contactable pharmacist (Patient himself).  A 34-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection Batch/Lot Number: EL1283 Expiration date: Unknown) via an intramuscular route of administration, administered in deltoid right on 12Jan2021 15:00 (at the age of 34-year-old) as dose 2, single for covid-19 immunization. Patient is non-smoker. Patient medical history was not reported. Concomitant medications included bupropion taken for an unspecified indication, start and stop date were not reported and ibuprofen taken for an unspecified indication from 23Dec2020 to an unspecified stop date. Patient previously received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot/Batch number- EJ1685) via intramuscular route of administration, on right deltoid on 23Dec2021 (at the age of 34-year-old) as dose 1, single for COVID-19 immunization and experienced diarrhea 24 hours of diarrhea from 01Jan2021, was diagnosis with covid-19 through nasopharyngeal NAAT. The patient underwent lab tests and procedures which included culture resulted as positive on organism was covid-19 culture source was Nasopharyngeal NAAT, sars-cov-2 antibody test resulted as negative on 22Feb2021. The patient experienced right subclavicular lymph nodes swelling on 13Jan2021 and covid-19-antibody (negative) on 22Feb2021. Patient had not attended Emergency Room and physician Office for the events reported. it was reported that it should also be noted that patient COVID-19 antibodies were negative after a blood donation on 22Feb2021. Patient was not hospitalized and patient was not admitted to an Intensive Care Unit. Patient had not developed clinical sign at rest indicative of severe system illness. Patient not required supplemental oxygen (including high flow or ECMO) or receive mechanical ventilation for the events reported. patient not had any Multiorgan failure. Event had not required the initiation of new medication or other treatment or procedure. Patient was not taking any medication routinely prior to the event and not been treated with immunomodulating or immunosuppressing or receive any other vaccines around the time of COVID-19 vaccination. Outcome of events was unknown. No follow-up attempts are possible. No further information is expected
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy, Oropharyngeal pain, Pyrexia, SARS-CoV-2 test
Clinical narrative: After the second dose sweeping in glands in opposite side of neck, throat and up to ear/Swelling in lymph nodes in axillary; fever; sore throat; This is a spontaneous report from a contactable Nurse. A 38-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number: En9581, Expiry date not reported) via unspecified route of administration, administered in left arm on 13Feb2021 (at age of 38-years-old) as dose 2, single for COVID-19 Immunisation. The patient medical history includes Polycystic ovaries (PCOS) and COVID-19. There are no known allergies reported. Patient previously received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number: El3248, Expiry date not reported) via unspecified route of administration, administered in left arm on 30Jan2021 at 09:00 (at age of 38-years-old) as dose 1, single for COVID-19 Immunisation and experienced swollen lymph nodes in arm of vaccine ancillary and basilic. Patient did not receive any other vaccine within 4 weeks prior to the COVID vaccine. Patient received Birth control within two weeks. The patient was diagnosed with COVID-19 prior to vaccination. The patient had tested for COVID-19 post vaccination with nasal swab. On 09Mar2021 at 12:00 (24 days 12 hrs after vaccination) After the second dose patient experienced sweeping in glands in opposite side of neck, throat and up to ear. Swelling in lymph nodes in axillary fever a month later and sore throat. Adverse Events resulted in doctor or other healthcare professional office/clinic visit. The Patient received treatment for adverse events with tested again and given Tamiflu. The Patient underwent lab test and procedures include nasal swab test result was unknown on 09Mar2021.The Outcome of the events was not recovered    No follow-up attempts are possible. No further information is expected.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Myalgia, Vertigo
Clinical narrative: Severe joint pain; Vertigo; muscle aches; This is a spontaneous report from a non-contactable consumer or other non hcp.   A 37-years-old female patient received BNT162b2 (CONMINTARY, Solution for injection, Lot No: was not reported), via an unspecified route of administration, administered in Arm Left on 10Mar2021 16:00 as unknown, single for covid-19 immunisation (age at vaccination was 37 years). Patient was not pregnant at time of vaccination. Medical history included migraine from an unknown date and unknown if ongoing, motion sickness from an unknown date and unknown if ongoing. Concomitant medication(s) included gabapentin (GABAPENTIN) taken for an unspecified indication, start and stop date were not reported.  The patient previously took reglan [metoclopramide] and experienced drug hypersensitivity, compazine [prochlorperazine maleate] and experienced drug hypersensitivity. The patient experienced severe joint pain, vertigo, muscle aches on an unspecified date. Therapeutic measures were taken as a result of vertigo (vertigo). Outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Pain, Pyrexia, Vaccination site pain
Clinical narrative: constant headache; Very tired; achy; low fever; injection site soreness; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 42-years-old female patient (non-pregnant) received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, SINGLE dose, Lot number EN6199, Expiration date: unknown), via an unspecified route of administration, administered in Arm Right on 10Mar2021 12:00 (at the age of 42-years-old) as DOSE NUMBER UNKNOWN, SINGLE for covid-19 immunisation. The patient was not pregnant at the time of vaccination. The medical history included hypertension, blood cholesterol increased, and anxiety. Concomitant medication included (other medications in two weeks) HYRDOCHLOROTHIAZIDE, LISINOPRIL, AMLODIPINE, AND LISINOPRIL. The patient previously took CELEBREX. The Patient's allergies to Celebrex, erythromycin, and NSAIDs. The patient not covid vaccination prior. The patient not covid tested post vaccination. The patient experienced Headache started 13 hours after shot. Tylenol didn't help. Had constant headache for 20 hours, Very tired, achy, low fever, and injection site soreness on 11Mar2021, 01:00 AM. The patient did not receive treatment for events except headache. The outcome of the events were recovered on an unspecified date in Mar2021.   No follow-up attempts are possible. No further information is expected.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Dry skin, Eczema, Erythema, Joint swelling, Peripheral swelling
Clinical narrative: the top of my left hand (starting at the wrist and including the fingers) was very red, dry, slightly swollen, and itchy; the top of my left hand (starting at the wrist and including the fingers) was very red, dry, slightly swollen, and itchy; the top of my left hand (starting at the wrist and including the fingers) was very red, dry, slightly swollen, and itchy; the top of my left hand (starting at the wrist and including the fingers) was very red, dry, slightly swollen, and itchy; the top of my left hand (starting at the wrist and including the fingers) was very red, dry, slightly swollen, and itchy; It looked a bit like eczema; This is a spontaneous report from a contactable consumer or other non healthcare professional. A 66 year old female patient received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration, administered in Arm Left on 09Mar2021 09:15 (Batch/Lot number was not reported) as DOSE 1, SINGLE for covid-19 immunisation. Medical history included goitre from an unknown date and unknown if ongoing, dermatitis contact from an unknown date and unknown if ongoing, drug hypersensitivity from an unknown date and unknown if ongoing have a sensitivity to penicillin, lanolin, toluene. Concomitant medication(s) included levothyroxine sodium (SYNTHROID) taken for an unspecified indication, start and stop date were not reported; famotidine (FAMOTIDINE) taken for an unspecified indication and vitamins, start and stop date were not reported. The patient experienced the top of her left hand starting at the wrist and including the fingers was very red, dry, slightly swollen, and itchy causing erythema on 10Mar2021 10:00 with outcome of recovered, dry skin on 10Mar2021 10:00 with outcome of recovered, itchy and peripheral swelling on 10Mar2021 10:00 with outcome of recovered, the  itchy and joint swelling on 10Mar2021 10:00 with outcome of recovered and it looked a bit like eczema on 10Mar2021 10:00 with outcome of recovered.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus
Clinical narrative: the top of my left hand (starting at the wrist and including the fingers) was very red, dry, slightly swollen, and itchy; the top of my left hand (starting at the wrist and including the fingers) was very red, dry, slightly swollen, and itchy; the top of my left hand (starting at the wrist and including the fingers) was very red, dry, slightly swollen, and itchy; the top of my left hand (starting at the wrist and including the fingers) was very red, dry, slightly swollen, and itchy; the top of my left hand (starting at the wrist and including the fingers) was very red, dry, slightly swollen, and itchy; It looked a bit like eczema; This is a spontaneous report from a contactable consumer or other non healthcare professional. A 66 year old female patient received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration, administered in Arm Left on 09Mar2021 09:15 (Batch/Lot number was not reported) as DOSE 1, SINGLE for covid-19 immunisation. Medical history included goitre from an unknown date and unknown if ongoing, dermatitis contact from an unknown date and unknown if ongoing, drug hypersensitivity from an unknown date and unknown if ongoing have a sensitivity to penicillin, lanolin, toluene. Concomitant medication(s) included levothyroxine sodium (SYNTHROID) taken for an unspecified indication, start and stop date were not reported; famotidine (FAMOTIDINE) taken for an unspecified indication and vitamins, start and stop date were not reported. The patient experienced the top of her left hand starting at the wrist and including the fingers was very red, dry, slightly swollen, and itchy causing erythema on 10Mar2021 10:00 with outcome of recovered, dry skin on 10Mar2021 10:00 with outcome of recovered, itchy and peripheral swelling on 10Mar2021 10:00 with outcome of recovered, the  itchy and joint swelling on 10Mar2021 10:00 with outcome of recovered and it looked a bit like eczema on 10Mar2021 10:00 with outcome of recovered.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Fatigue, Feeling cold, Lethargy, Pain
Clinical narrative: felt chilled; temp was 100.3. The highest it got was 101.7; felt lethargic; achey; sore arm; fatigue; This is a spontaneous report from a contactable consumer (patient). A 71-year-old non pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: EL9267) (at the age 71-year-old), via an unspecified route of administration, administered in arm right on 17Feb2021 16:00 as dose 2, single for covid-19 immunization. The patient previously received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: EL9261), dose 1, on 27Jan2021 04.15 PM on right arm for covid-19 immunization. Patient known allergies includes daypro and morphine. The patient relevant medical history includes HTN, GERD, fibromyalgia, arthritis, history of Breast Cancer. The patient concomitant medications were not reported in two weeks. The patient was not pregnant at the time of vaccination. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. It was reported that about 22-23 hrs after her 2nd dose, (on 18Feb2021 at 14:30) the patient felt chilled and temperature was 100.3 and the highest it got was 101.7. The patient felt lethargic and achey. Except for a sore arm and fatigue the side effects was gone when the patient woke up the following morning. The patient underwent lab test on 18Feb2021: body temperature: 100.3 and 101.7 Fahrenheit. The patient did not received treatment for adverse event. The patient did not had prior vaccination for covid. The patient did not tested for covid post vaccination. The outcome of feeling cold, pyrexia, lethargic and pain was recovered on an unspecified date in 2021. The outcome of pin in extremity and fatigue was not recovered.  No follow-up attempts are possible. No further information is expected.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Pyrexia
Clinical narrative: felt chilled; temp was 100.3. The highest it got was 101.7; felt lethargic; achey; sore arm; fatigue; This is a spontaneous report from a contactable consumer (patient). A 71-year-old non pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: EL9267) (at the age 71-year-old), via an unspecified route of administration, administered in arm right on 17Feb2021 16:00 as dose 2, single for covid-19 immunization. The patient previously received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: EL9261), dose 1, on 27Jan2021 04.15 PM on right arm for covid-19 immunization. Patient known allergies includes daypro and morphine. The patient relevant medical history includes HTN, GERD, fibromyalgia, arthritis, history of Breast Cancer. The patient concomitant medications were not reported in two weeks. The patient was not pregnant at the time of vaccination. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. It was reported that about 22-23 hrs after her 2nd dose, (on 18Feb2021 at 14:30) the patient felt chilled and temperature was 100.3 and the highest it got was 101.7. The patient felt lethargic and achey. Except for a sore arm and fatigue the side effects was gone when the patient woke up the following morning. The patient underwent lab test on 18Feb2021: body temperature: 100.3 and 101.7 Fahrenheit. The patient did not received treatment for adverse event. The patient did not had prior vaccination for covid. The patient did not tested for covid post vaccination. The outcome of feeling cold, pyrexia, lethargic and pain was recovered on an unspecified date in 2021. The outcome of pin in extremity and fatigue was not recovered.  No follow-up attempts are possible. No further information is expected.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Migraine, Pain, Pyrexia, SARS-CoV-2 test
Clinical narrative: Severe chills; body aches; Low fever; Migraine; This is a spontaneous report from a contactable Consumer. This 48-Year-old Female Consumer (patient) reported A 48-years-old non-pregnant female patient (not pregnant at the time of vaccination) received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot Number: EN6202), via an unspecified route of administration, administered in Left arm on 09Mar2021 14:45 (at the age of 48-years-old) as dose 1, single for covid-19 immunisation. The patient medical history included hypothyroidism from an unknown date and unknown if ongoing, Iron Deficiency woyh Anemia from an unknown date and unknown if ongoing. The patient had no known allergies. The patient concomitant medications included levothyroxine sodium (SYNTHROID) taken for an unspecified indication, start and stop date were not reported, liothyronine (LIOTHYRONINE) taken for an unspecified indication, start and stop date were not reported, escitalopram (ESCITALOPRAM) taken for an unspecified indication, start and stop date were not reported and melatonin (MELATONIN) taken for an unspecified indication, start and stop date were not reported. The patient had not taken other vaccine in four weeks. The patient had not been tested for covid, prior vaccination. The patient had been tested for covid, post vaccination. On an unspecified date on Mar2021, the patient experienced Severe chills and body aches, Low fever and Migraine. Low fever, Migraine that does not respond to pain medication. The patient not received treatment for events severe chills and body aches. The events resulted in Emergency/urgent care visit. The patient underwent lab tests and procedures which included sars-cov-2 test (nasal swab) negative, on 15Mar2021. The clinical outcome of the events was not recovered.  No follow-up attempts are possible. No further information is expected.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Erythema, Peripheral swelling
Clinical narrative: Two hands were swollen; both arms were redness; This is a spontaneous report from a contactable consumer (Patient). A 66-year-old male received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: solution for injection, Lot number: EL9269-EN6203) via an unspecified route of administration, administered on left arm on 23Feb2021 11:00 AM as dose 2, single (at the age of 66-year-old) for COVID-19 immunization. Medical history included Placed stient on 02Nov2014 for an unknown indication, heart bypass surgery 02Apr2019 for an unknown indication, diabetes, high blood pressure and lipid disorder all were from an unknown date and unknown if ongoing. Concomitant medications include (within 2 weeks of vaccination) medications for High blood pressure, lipid disorder, Diabetes all are from an unknown date. Patient did not have any allergy to medications, food, or other products. Prior to vaccination, patient was diagnosed with covid. Since the vaccination, the patient has not been tested for COVID-19. Historical vaccine included BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: solution for injection, Lot number: not reported) via an unspecified route of administration, on an unspecified date as dose 1, single for COVID-19 immunization and Flu Vaccine via an unspecified route of administration, administered in left arm on 11Aug2020 11:00 as dose 1, single for immunisation. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Hospital was the Facility where the most recent COVID-19 vaccine was administered. It was reported that on 06Mar2021 after 2 weeks of vaccination of the second batch, two hands were swollen and both arms were redness. Patient received treatment for the events, therapeutic measures were taken as a result of the events and included Cortizone, levocetirizine 5 mg. Outcome of the event was Not recovered.  No follow-up attempts are needed; No further information is expected
Sex: F
Vaccine: COVID19
Symptoms: Headache, Rash erythematous, Ulcer
Clinical narrative: open sore; red rash on her skin; mild headache; This is a spontaneous report from Pfizer sponsor program. A contactable consumer (reported for herself). A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date as dose number unknown, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. On an unspecified date, the patient experienced open sore, red rash on her skin and mild headache. The outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Breast pain, Chills, Dyspnoea
Clinical narrative: Left breast pain and slight shortness of breath began on Sunday am, day after vaccine.; Left breast pain and slight shortness of breath began on Sunday am, day after vaccine.; chills; upset stomach; This is a spontaneous report from a contactable consumer (Patient) who reported for herself.  A 63-years-old female received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported) via an unspecified route of administration on 13Mar2021 at 04:45 (at the age of 63-years-old), administered in left arm as a dose number unknown, single dose for COVID-19 immunization. Medical history included allergy to Sulfa drugs, birch protein and pollen and epilepsy from an unspecified date. Concomitant medications included Levetiracetam from an unknown start date for unspecified indication. The patient had no other vaccine in 4 weeks. The patient did not have COVID prior to vaccination and was not tested for COVID post vaccination. On 14Mar2021 at 10:00, the patient experienced Left breast pain and slight shortness of breath began on Sunday am, day after vaccine. Also chills and upset stomach on 14Mar2021 at 10:00. No treatment was received for adverse events. The clinical outcome of all the events was recovering.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Feeling hot, Hyperhidrosis, Malaise
Clinical narrative: Chills; Achiness; Tiredness; Felt hot; Didn't feel good; I don't know if had fever I checked but I was sweaty; This is a spontaneous report from a contactable consumer, the patient. A 85-year-old female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, lot number: EN6200), dose 2 via an unspecified route of administration on an unspecified date as dose 2, single (at the age of 85-year-old) for COVID-19 immunization. Medical history included ongoing hypertension, anaemia, blood cholesterol abnormal, cardiac disorder and stent placement. Concomitant medication included rosuvastatin calcium (CRESTOR) taken for blood cholesterol abnormal. Patient take unspecified high blood pressure medications. Patient was about to take Prolin shot for bones. but was advised to wait for 2 weeks. She asked if it was okay to take it afterwards. It was reported that the patient got the vaccine, second one on Monday. Monday, she felt okay and on Tuesday felt okay till the afternoon and then started getting the chills and achy and tired and then felt hot, did not know if had fever patient checked but she was sweaty when went back to lay down on bed so that lasted from about 3 o'clock in the afternoon and then the next morning which would have been Wednesday morning. The patient felt pretty good but not exactly like she should but then felt pretty good that day and then yesterday that was Thursday around 2 or 3 o'clock the same time patient started getting the same things, the chills and the achiness and tiredness and just did not feel good and then this morning patient was felt better but just tired. Patient reported vaccination date as The 8th, March 8th. Consumer stated, she think she was 5 feet 3 inches and 140 pounds. The patient did not receive any treatment for the events. The outcome of the events was unknown.  No follow-up attempts were possible. No further information was expected.
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Pain
Clinical narrative: Chills; Achiness; Tiredness; Felt hot; Didn't feel good; I don't know if had fever I checked but I was sweaty; This is a spontaneous report from a contactable consumer, the patient. A 85-year-old female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, lot number: EN6200), dose 2 via an unspecified route of administration on an unspecified date as dose 2, single (at the age of 85-year-old) for COVID-19 immunization. Medical history included ongoing hypertension, anaemia, blood cholesterol abnormal, cardiac disorder and stent placement. Concomitant medication included rosuvastatin calcium (CRESTOR) taken for blood cholesterol abnormal. Patient take unspecified high blood pressure medications. Patient was about to take Prolin shot for bones. but was advised to wait for 2 weeks. She asked if it was okay to take it afterwards. It was reported that the patient got the vaccine, second one on Monday. Monday, she felt okay and on Tuesday felt okay till the afternoon and then started getting the chills and achy and tired and then felt hot, did not know if had fever patient checked but she was sweaty when went back to lay down on bed so that lasted from about 3 o'clock in the afternoon and then the next morning which would have been Wednesday morning. The patient felt pretty good but not exactly like she should but then felt pretty good that day and then yesterday that was Thursday around 2 or 3 o'clock the same time patient started getting the same things, the chills and the achiness and tiredness and just did not feel good and then this morning patient was felt better but just tired. Patient reported vaccination date as The 8th, March 8th. Consumer stated, she think she was 5 feet 3 inches and 140 pounds. The patient did not receive any treatment for the events. The outcome of the events was unknown.  No follow-up attempts were possible. No further information was expected.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Body height, Feeling hot, Pain in extremity, Rash
Clinical narrative: My arm felt more sore; It is just pinky red and sometimes it feels warm/there is a rash around it is 3 inches now round; It is just pinky red and sometimes it feels warm/there is a rash around it is 3 inches now round; This is a spontaneous report from a contactable consumer (patient herself) .  An 80-years-old female received bnt162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number: ENV202, Expiry Date-Unknown) via an unspecified route of administration on 04Mar2021 as DOSE 2, SINGLE (at the age of 80-years-old) for COVID-19 immunisation. The patient medical history and concomitant medication were not reported. On 10Mar2021 (6 days after the vaccination), patient experienced arm felt more sore, It is just pinky red and sometimes it feels warm/there is a rash around it is 3 inches now round. Patient got her second shot on 04Mar2021 and yesterday noticed that her arm felt more sore and there was a rash around it was 3 inches now round but today it was pink. Last night it was more red. Patient did not had a temperature and is this was normal reaction. Patient stated height was 5 and may be one quarter. Patient stated it does not hurt or anything. It is just pinky red and sometimes it feels warm. Otherwise it does not bother her but it is like okay. The outcome of arm felt more sore was recovered on an unspecified date in Mar2021 and remaining events outcome were unknown.  No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Rash macular, Swelling face
Clinical narrative: This is a spontaneous report from a noncontactable consumer (patient). A female patient, of an unspecified age, received the 1st dose of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, batch/lot# not reported), via an unspecified route of administration, on Mar 10, 2021, single dose, for COVID-19 immunisation. The patient's medical history and concomitant medications not reported. On an unspecified date, the side of her face became swollen with red spots. The outcome of the events: unknown. No follow-up attempts possible. Information about lot/batch number cannot be obtained.
Sex: U
Vaccine: COVID19
Symptoms: Pruritus, Urticaria
Clinical narrative: I had hives and scratching all over; I had hives and scratching all over; This is a spontaneous report received from a contactable consumer or other non hcp. A patient of unspecified age and gender received bnt162b2 (Pfizer covid19 vaccine,Batch/Lot number was not reported), via an unspecified route of administration on 11Mar2021, as Dose number unknown,single for covid-19 immunization.The patient medical history and concomitant medications were not reported.The patient experienced hives and scratching all over on Mar2021.The Consumer was informed about Pfizer Medical information department and was provided with the number.Product details (LOT#, expiration date, NDC# and UPC#) and other details were unknown as the Consumer hung up the call abruptly.The outcome of the events was unknown.  No follow-up attempts are possible; information about batch/ lot number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Abnormal sensation in eye, Chest discomfort, Chest pain, Erythema, Lacrimation increased
Clinical narrative: face tingle; little itchy; eyes were really red and watering; eyes were really red and watering; chest felt like I had bronchitis; fever; burning in her chest; arms are red; she has been scratching; my face was red and itching; eyes were really red and watering could feel as if she had a cold in her eye; This is a spontaneous report from a contactable consumer(patient). A female patient of an (Age:50, Unit: Unknown) received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot number: not reported), via an unspecified route of administration on 11Mar2021 as DOSE NUMBER UNKNOWN, SINGLE for covid-19 immunisation. Medical history included panic attack . The patient's concomitant medications were not reported. Patient got a shot on Thursday and had certain signs and symptoms, and this could just be side effects of getting the vaccine. Reporter states, when I got the shot and on an unspecified date in 2021, I felt my face tingle and it was a little itchy but I ignored it because I've had a panic attack in the past. Later my arms were red and itching and my face was red and itching. My eyes started watering later and yesterday my eyes were really red and watering could feel as if she had a cold in her eye. On Sunday my chest felt like I had bronchitis coming on. I had a fever. Caller states she was itching, said it started that she could feel a tingle on her face and then progressed, states her arms are red and she has been scratching. Stated she took Benadryl to treat it, noticed her eyes have been watering, states yesterday eyes were red and watering, could feel as if she had a cold in her eye, last night she had a fever and she was going to go to the doctor, also felt burning in her chest on Sunday. Caller is unsure if this has anything to do with the vaccine, states she wanted to call to see if anyone else had reported similar symptoms. Patient had burning in her chest. The outcome of the events was unknown.  No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Ocular hyperaemia, Paraesthesia, Pruritus, Pyrexia, Scratch
Clinical narrative: face tingle; little itchy; eyes were really red and watering; eyes were really red and watering; chest felt like I had bronchitis; fever; burning in her chest; arms are red; she has been scratching; my face was red and itching; eyes were really red and watering could feel as if she had a cold in her eye; This is a spontaneous report from a contactable consumer(patient). A female patient of an (Age:50, Unit: Unknown) received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot number: not reported), via an unspecified route of administration on 11Mar2021 as DOSE NUMBER UNKNOWN, SINGLE for covid-19 immunisation. Medical history included panic attack . The patient's concomitant medications were not reported. Patient got a shot on Thursday and had certain signs and symptoms, and this could just be side effects of getting the vaccine. Reporter states, when I got the shot and on an unspecified date in 2021, I felt my face tingle and it was a little itchy but I ignored it because I've had a panic attack in the past. Later my arms were red and itching and my face was red and itching. My eyes started watering later and yesterday my eyes were really red and watering could feel as if she had a cold in her eye. On Sunday my chest felt like I had bronchitis coming on. I had a fever. Caller states she was itching, said it started that she could feel a tingle on her face and then progressed, states her arms are red and she has been scratching. Stated she took Benadryl to treat it, noticed her eyes have been watering, states yesterday eyes were red and watering, could feel as if she had a cold in her eye, last night she had a fever and she was going to go to the doctor, also felt burning in her chest on Sunday. Caller is unsure if this has anything to do with the vaccine, states she wanted to call to see if anyone else had reported similar symptoms. Patient had burning in her chest. The outcome of the events was unknown.  No follow-up attempts are possible. No further information is expected.